Diagnosis and Management of Intrauterine Growth Restriction and Congenital Anomalies

Launched by GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER · Jan 6, 2018

Keywords

ClinConnect Summary

This clinical trial is focused on understanding and managing conditions that affect babies before they are born, specifically intrauterine growth restriction (IUGR) and certain congenital anomalies (birth defects). The study aims to gather important medical information and biological samples from pregnant women and their babies to help improve diagnosis and treatment options for these conditions. By collecting this data, researchers hope to enhance how we manage pregnancies complicated by these issues.

If you are a pregnant woman who has been diagnosed with IUGR or a structural or chromosomal anomaly, you may be eligible to participate in this study. Participants will provide information about their pregnancy and, after delivery, about their baby's health. It’s important to note that women who choose not to participate or are delivering at other hospitals will not be included. The trial is currently recruiting and welcomes all pregnant women regardless of age or gender. Your involvement could contribute to vital research that helps future families facing similar challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• All pregnant women who present to Guangzhou Women and Children's Medical Center meeting one of the following prenatal diagnoses and neonates/infants who are diagnosed as one of the following anomalies will be invited to participate:
• • 1. Intrauterine growth restriction (IUGR)
• • 2. Structural anomaly
• • 3. Chromosomal anomaly
• Exclusion Criteria:
• • 1. Pregnant women who don't agree to participate;
• • 2. Pregnant women delivering babies at other hospitals.
• • 3. Prenatally suspected anomalies that are not confirmed by postnatal diagnosis.